Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease

References

• Stollman NH, Raskin JB. Diverticular disease of the colon. J Clin Gastroenterol 1999; 29: 241–52
   PubMed Web of Science ®Google Scholar
• Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, et al. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 2000; 120: 241–6
   PubMed Web of Science ®Google Scholar
• McKaig BC, McWilliams D, Watson SA, Mahida YR. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol 2003; 162: 1355–60
   PubMed Web of Science ®Google Scholar
• Bamba S, Andoh A, Yasui H, Araki Y, Bamba T, Fujiyama Y. Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. J Gastroenterol 2003; 38: 548–54
   PubMed Web of Science ®Google Scholar
• Falk P, Ivarsson ML. Examination gloves affect secretion of matrix metalloproteinases and their inhibitors from human abdominal skin fibroblasts. Wound Repair Regen 2003; 11: 230–4
   PubMed Web of Science ®Google Scholar
• Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 1683–99
   PubMed Web of Science ®Google Scholar
• Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 1998; 152: 1005–14
   PubMed Web of Science ®Google Scholar
• von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000; 47: 63–73
   PubMed Web of Science ®Google Scholar
• Okuno T, Andoh A, Bamba S, Araki Y, Fujiyama Y, Fujiyama M, et al. Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol 2002; 37: 317–24
   PubMed Web of Science ®Google Scholar
• Parks WC. Matrix metalloproteinases in repair. Wound Repair Regen 1999; 7: 423–32
   PubMed Web of Science ®Google Scholar
• Tarlton JF, Whiting CV, Tunmore D, Bregenholt S, Reimann J, Claesson MH, et al. The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis. Am J Pathol 2000; 157: 1927–35
   PubMed Web of Science ®Google Scholar
• Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P, et al. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer 1995; 64: 70–5
   PubMedGoogle Scholar
• Stumpf M, Cao W, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V. Increased distribution of collagen type III and reduced expression of matrix metalloproteinase 1 in patients with diverticular disease. Int J Colorectal Dis 2001; 16: 271–5
   PubMed Web of Science ®Google Scholar
• Brown PD. Matrix metalloproteinases in gastrointestinal cancer. Gut 1998; 43: 161–3
   PubMedGoogle Scholar
• Mimura, T, Bateman, AC, Lee, RL, Johnson, PA, McDonald, PJ, Talbot, IC, , et al. Up-regulation of collagen and tissue inhibitors of matrix metalloproteinase in colonic diverticular disease. Dis Colon Rectum 2004;47:371–8; discussion:378–9.
   PubMed Web of Science ®Google Scholar
• Syk I, Agren MS, Adawi D, Jeppsson B. Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model. Br J Surg 2001; 88: 228–34
   PubMed Web of Science ®Google Scholar
• Savage FJ, Lacombe DL, Hembry RM, Boulos PB. Effect of colonic obstruction on the distribution of matrix metalloproteinases during anastomotic healing. Br J Surg 1998; 85: 72–5
   PubMedGoogle Scholar
• Stumpf M, Cao W, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V. Collagen distribution and expression of matrix metalloproteinases 1 and 13 in patients with anastomotic leakage after large-bowel surgery. Langenbecks Arch Surg 2002; 386: 502–6
   PubMed Web of Science ®Google Scholar
• Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, et al. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 1999; 44: 17–25
   PubMed Web of Science ®Google Scholar
• Louka AS, Stensby EK, Ek J, Gudjonsdottir AH, Ascher H, Sollid LM. Coeliac disease candidate genes: no association with functional polymorphisms in matrix metalloproteinase 1 and 3 gene promoters. Scand J Gastroenterol 2002; 37: 931–5
   PubMed Web of Science ®Google Scholar
• Salmela MT, Karjalainen-Lindsberg ML, Jeskanen L, Saarialho-Kere U. Overexpression of tissue inhibitor of metalloproteinases-3 in intestinal and cutaneous lesions of graft-versus-host disease. Mod Pathol 2003; 16: 108–14
   PubMedGoogle Scholar
• Brynskov J, Foegh P, Pedersen G, Ellervik C, Kirkegaard T, Bingham A, et al. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut 2002; 51: 37–43
   PubMed Web of Science ®Google Scholar
• Stallmach A, Chan CC, Ecker KW, Feifel G, Herbst H, Schuppan D, et al. Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut 2000; 47: 415–22
   PubMed Web of Science ®Google Scholar
• Otani Y, Sakurai Y, Kameyama K, Igarashi N, Yokoyama T, Kubota T, et al. Matrix metalloproteinase gene expression in chronic gastric ulcer: a potential role of eosinophils in perforation. J Clin Gastroenterol 1997; 25(Suppl 1)S101–4
   Google Scholar
• Tatsuguchi A, Fukuda Y, Ishizaki M, Yamanaka N. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs. Digestion 1999; 60: 246–54
   PubMedGoogle Scholar
• Shahin M, Konturek JW, Pohle T, Schuppan D, Herbst H, Domschke W. Remodeling of extracellular matrix in gastric ulceration. Microsc Res Tech 2001; 53: 396–408
   PubMedGoogle Scholar
• Langenskiold M, Holmdahl L, Falk P, Ivarsson ML. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int J Colorectal Dis 2005; 20: 245–52
   PubMed Web of Science ®Google Scholar
• Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002; 3: 207–14
   PubMed Web of Science ®Google Scholar
• Baxter BT, Pearce WH, Waltke EA, Littooy FN, Hallett JW, Jr, Kent KC, et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg 2002; 36: 1–12
   PubMed Web of Science ®Google Scholar